IDDI speaking at KCE Trials Symposium 2023
May 25, 2023
IDDI’s Founder, CSO Marc Buyse, ScD is speaking at the 4th KCE Trials Symposium 2023 in Brussels, Belgium on May 25!
Join Marc Buyse, ScD, IDDI’s Founder & CSO as he’s presenting about Generalized Pairwise Comparison, a nouveau innovative statistical method paving the way to personalized medicine at the 4th KCE Trials Symposium.
The presentation titled:
NEW STATISTICAL METHODS FOR PATIENT-CENTRED OUTCOMES IN RANDOMIZED CLINICAL TRIALS
It will be delivered at 9:55 AM CEST on Thursday, May 25, 2023.
Generalized Pairwise Comparisons (GPC) is a new method and new tools for the design and analysis of clinical trials, with the objective of involving patients and clinicians in the analysis and place them at the center of the therapeutic decision
WE LOOK FORWARD TO SEEING YOU AT KCE TRIALS SYMPOSIUM 2023!
IDDI is an expert clinical data services and high-level strategic consulting contract research organization (CRO), providing agile clinical trials services for pharmaceutical, biotech, and medical device/diagnostic companies.
With a proven track record, IDDI provides expert Biostatistics and eClinical Services to ensure the successful execution of your clinical development program.
About Marc Buyse, ScD – Founder & CSO, the International Drug Development Instittute
Marc Buyse, ScD, Chief Scientific Officer and Founder, IDDI
Marc holds a ScD in biostatistics from the Harvard School of Public Health (Boston, MA). He is the founder of the International Drug Development Institute (IDDI) and of CluePoints, two biostatistical service organizations based in the US and Europe. He is interested in clinical trial design, meta-analysis, validation of biomarkers and surrogate endpoints, statistical methods in oncology, statistical detection of errors and fraud, statistical monitoring of clinical trials, and medical data sharing.